BMPR1A — Bone Morphogenetic Protein Receptor Type 1A
<div class="infobox infobox-gene">
<div class="infobox-header">BMPR1A</div>
<div class="infobox-row"><strong>Full Name:</strong> Bone Morphogenetic Protein Receptor Type 1A</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 10q22.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> NCBI Gene 595</div>
<div class="infobox-row"><strong>OMIM:</strong> 604798</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000107779</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O00238</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Juvenile polyposis syndrome, Pulmonary arterial hypertension, Fibrodysplasia ossificans progressiva, Alzheimer's disease, Parkinson's disease</div>
</div>
Overview
BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), also known as ALK3 (Activin receptor-Like Kinase 3), is a transmembrane serine/threonine kinase receptor that plays critical roles in embryonic development, skeletal formation, tissue homeostasis, and central nervous system function [1]. BMPR1A is a key component of the [BMP signaling pathway](/mechanisms/bmp-signaling-pathway) and mediates signaling for multiple BMP ligands including BMP2, BMP4, BMP6, and BMP7.
In the nervous system, BMPR1A regulates neural stem cell proliferation and differentiation, dopaminergic neuron development, synaptic plasticity, and neuroprotection. Dysregulated BMP signaling through BMPR1A has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), amyotrophic lateral sclerosis (ALS), and other neurodegenerative conditions [2][3].
The gene is located on chromosome 10q22.3, encodes a 532-amino acid protein with a molecular weight of approximately 60 kDa, and is widely expressed throughout the brain with particularly high levels in the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum.
Function
Receptor Structure and Signaling
BMPR1A is a type I serine/threonine kinase receptor consisting of:
- Extracellular domain: Ligand-binding region with cysteine-rich motifs
- Transmembrane domain: Single-pass membrane anchor
- Cytoplasmic serine/threonine kinase domain: Intrinsic kinase activity for signal transduction
BMPR1A functions as the primary BMP type I receptor, binding BMP ligands with high affinity. Upon ligand binding, BMPR1A forms a heteromeric complex with type II receptors (BMPR2, ACVR2A, ACVR2B) [1]. The type II receptor phosphorylates the GS domain (glycine-serine rich domain) of BMPR1A, activating its kinase domain. Activated BMPR1A then phosphorylates downstream SMAD effectors.
SMAD-Dependent Signaling
The canonical BMPR1A signaling pathway involves:
SMAD1/5/8 phosphorylation: Activated BMPR1A phosphorylates receptor-regulated SMADs (R-SMADs)
SMAD complex formation: Phosphorylated SMAD1/5/8 forms complexes with SMAD4 (co-SMAD)
Nuclear translocation: The SMAD complex translocates to the nucleus
Gene transcription regulation: SMAD complexes bind DNA and regulate transcription of target genesThis pathway controls:
- Neural stem cell fate decisions
- Neuronal differentiation
- Axon guidance
- Dendrite morphogenesis
- Synapse formation and plasticity
Non-Canonical Signaling
BMPR1A also signals through non-SMAD pathways:
- MAPK pathways: Activation of ERK, JNK, and p38 MAPK
- PI3K/AKT pathway: Pro-survival signaling
- Rho GTPase pathways: Cytoskeletal regulation
- Wnt cross-talk: Interaction with canonical Wnt/β-catenin signaling
Neural Stem Cell Regulation
BMPR1A plays a critical role in neural stem cell (NSC) biology [4]:
Proliferation: BMP signaling promotes NSC proliferation in the subventricular zone and hippocampus
Differentiation: BMPR1A-mediated signaling influences neuronal versus glial fate decisions
Maintenance: Continuous BMP signaling maintains NSC pools
Neurogenesis: Regulates the generation of new neurons in adult brainSynaptic Function
In mature neurons, BMPR1A regulates:
- Synapse formation: Dendritic spine development and presynaptic differentiation
- Synaptic plasticity: Long-term potentiation (LTP) and depression (LTD)
- Neurotransmitter regulation: Modulation of GABAergic and glutamatergic signaling
- Axon guidance: Pathfinding during development and regeneration
Expression Pattern
Brain Regional Distribution
BMPR1A exhibits a widespread expression pattern throughout the brain:
- Cerebral cortex: High expression in layers II-VI, particularly in pyramidal neurons
- Hippocampus: Strong expression in CA1-CA3 regions and dentate gyrus granule cells
- Basal ganglia: High levels in striatum and substantia nigra
- Cerebellum: Purkinje cells and granule cells
- Thalamus and hypothalamus: Moderate expression
- Brainstem: Motor nuclei and sensory relay regions
Cellular Expression
Within the brain, BMPR1A is expressed in:
- Neurons: Both excitatory and inhibitory neurons
- Astrocytes: Astrocytic BMPR1A regulates neuroinflammation
- Oligodendrocytes: Myelinating oligodendrocyte precursors
- Neural stem cells: Ventricular zone and subventricular zone
- Microglia: Modulates microglial activation states
Developmentally Regulated Expression
BMPR1A expression is dynamically regulated:
- High during embryonic neurogenesis
- Maintained in adult neurogenic niches
- Altered in aging and disease states
Disease Associations
Alzheimer's Disease
BMPR1A dysfunction is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms [2]:
Amyloid-beta toxicity: Altered BMP signaling affects neuronal sensitivity to [amyloid-beta](/proteins/amyloid-beta) toxicity
Tau pathology: BMP-SMAD signaling interacts with tau phosphorylation pathways
Neuroinflammation: BMPR1A in astrocytes regulates inflammatory responses [5]
Synaptic dysfunction: Impaired synaptic plasticity and memory formation
Neurogenesis impairment: Reduced hippocampal neurogenesis in ADThe interplay between BMP signaling and amyloid pathology involves:
- BMP2/4 expression is altered in AD brains
- SMAD signaling is dysregulated
- Inflammatory cytokines modulate BMPR1A expression
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), BMPR1A plays both protective and pathogenic roles [3]:
Dopaminergic neuron survival: BMP signaling promotes dopaminergic neuron survival
Neuroinflammation: Astrocytic BMPR1A modulates microglia-mediated inflammation
Alpha-synuclein interaction: BMP signaling may influence [alpha-synuclein](/proteins/alpha-synuclein) aggregation
Therapeutic potential: BMP receptor activation may provide neuroprotectionAmyotrophic Lateral Sclerosis (ALS)
BMPR1A signaling is dysregulated in ALS [6]:
- Altered BMP signaling in motor neurons
- Glial cell contributions to disease progression
- Potential therapeutic target for motor neuron protection
Cancer
While not directly neurodegenerative, BMPR1A is also associated with:
- Juvenile polyposis syndrome (gastrointestinal polyps)
- Pulmonary arterial hypertension
- Fibrodysplasia ossificans progressiva
- Various cancers (altered BMP signaling in tumor progression)
Molecular Mechanisms in Neurodegeneration
Amyloid-Beta Interactions
In Alzheimer's disease, BMPR1A signaling interacts with amyloid pathology through:
Receptor regulation: Amyloid-beta downregulates BMPR1A expression
Signal transduction: Impairs downstream SMAD signaling
Synaptic dysfunction: Disrupts BMP-mediated synaptic plasticity
Inflammatory amplification: Synergistic effects with neuroinflammationTau Phosphorylation
BMPR1A-SMAD signaling influences tau pathology:
- SMAD proteins can interact with tau kinases
- BMP signaling modulates tau phosphorylation status
- Therapeutic modulation of BMP signaling may reduce tau pathology
Neuroinflammation
BMPR1A in glial cells regulates neuroinflammation [5]:
- Astrocytic BMPR1A: Anti-inflammatory effects in some contexts
- Microglial activation: BMP signaling modulates microglial phenotypes
- Cytokine cross-talk: Inflammatory cytokines alter BMPR1A expression
Neurogenesis and Repair
BMPR1A signaling is crucial for:
- Adult hippocampal neurogenesis (memory function)
- Subventricular zone neurogenesis (olfactory function)
- Neuronal replacement potential (therapeutic applications)
Therapeutic Implications
Small Molecule Modulators
BMP receptor agonists: Synthetic BMP analogs for neuroprotection
Kinase inhibitors: Selective BMPR1A inhibitors (for pathological signaling)
SMAD pathway modulators: Downstream pathway targetsBiological Approaches
BMP protein therapy: Direct BMP delivery to affected brain regions
Gene therapy: AAV-mediated BMPR1A expression or modulation
Cell therapy: Stem cells engineered to express BMP ligandsTarget Validation
BMPR1A represents a compelling therapeutic target because:
- Genetic evidence: GWAS hits in BMPR1A region for PD and AD
- Mechanistic rationale: Clear role in neuronal survival and neuroinflammation
- Accessibility: Can be targeted with biologics or small molecules
- Druggability: Multiple therapeutic modalities available
Biomarkers
BMPR1A-related biomarkers could include:
- CSF BMP ligand levels[@bmpr1a_csf]
- BMPR1A expression in blood cells
- SMAD phosphorylation status
- Exosomal BMP signaling molecules
Clinical Evidence
Alzheimer's Disease Studies
Clinical evidence for BMPR1A involvement in AD includes:
Post-mortem brain studies: Altered BMPR1A expression and signaling in AD hippocampus[@bmpr1a_ad2021]
Genetic studies: BMPR1A polymorphisms associated with AD risk in genome-wide studies
Biomarker studies: Elevated BMP ligands in AD CSF[@bmpr1a_csf]
iPSC studies: BMP signaling dysregulation in AD patient-derived neurons[@bmpr1a_iPSC]Parkinson's Disease Studies
In Parkinson's disease:
Genetic association: BMPR1A variants linked to PD susceptibility[@bmpr1a_pd2022]
Post-mortem studies: Altered BMP receptor expression in substantia nigra
Neuroimaging: BMP-related markers correlate with disease progression
Therapeutic trials: BMP agonists in clinical trials for PDAmyotrophic Lateral Sclerosis
ALS research reveals:
- Dysregulated BMP signaling in motor neuron disease[@samantaray2015]
- Glial contribution to altered BMP signaling
- Potential therapeutic target
Biomarker Development
BMPR1A offers biomarker potential:
- Blood-based BMPR1A measurements
- SMAD phosphorylation as activity marker
- CSF BMP ligand profiling
- Imaging-based approaches
Animal Models
Transgenic Mouse Models
BMPR1A conditional knockout mice: Cell-type-specific deletion
- Neural stem cell-specific knockout: Neurogenesis impairment
- Neuron-specific knockout: Synaptic dysfunction
- Astrocyte-specific knockout: Neuroinflammation alterations
BMPR1A overexpression transgenic mice: Gain-of-function models
- Enhanced BMP signaling
- Altered neuronal survival
Humanized BMPR1A knock-in mice: Engineered for drug testingRodent Models of Neurodegeneration
- MPTP model of PD: BMP signaling alterations
- 6-OHDA model: BMPR1A changes in dopaminergic system
- APP/PS1 model of AD: BMP pathway disruption
- SOD1 model of ALS: Motor neuron BMP signaling
Zebrafish Models
- Developmental studies of BMP in CNS
- Real-time imaging of signaling dynamics
- High-throughput drug screening
Regional Expression in the Brain
Cerebral Cortex
BMPR1A exhibits distinct regional expression patterns within the brain:
- Cortical layers: Highest expression in layers II-VI, particularly in pyramidal neurons of layers III and V
- Cortical interneurons: Moderate expression in GABAergic interneurons
- Developmental expression: Peaks during cortical development
Hippocampus
The hippocampus shows particularly strong BMPR1A expression:
- CA1 region: High expression in pyramidal neurons
- CA2 region: Moderate expression
- CA3 region: High expression in pyramidal cells
- Dentate gyrus: Expression in granule cells and hilus
- Subgranular zone: Neural stem cell populations
Basal Ganglia
In the basal ganglia:
- Striatum: High expression in medium spiny neurons
- Substantia nigra: Expression in dopaminergic neurons[@andries2019]
- Globus pallidus: Moderate expression
Cerebellum
Cerebellar expression patterns:
- Purkinje cells: High BMPR1A expression
- Granule cells: Expression in cerebellar granule layer
- Molecular layer: Interneuron expression
BMPR1A in Specific Cell Types
Neurons
BMPR1A in neurons regulates multiple functions:
- Dendritic arborization: Controls dendritic growth and branching
- Synaptic formation: Promotes excitatory synapse formation
- Electrophysiology: Modulates ion channel function
- Metabolism: Regulates neuronal energy homeostasis
Astrocytes
Astrocytic BMPR1A has unique functions[@bmpr1a_glia]:
- Neuroinflammation: Regulates astrocyte-mediated inflammation
- Metabolic support: Modulates lactate and neurotransmitter recycling
- Blood-brain barrier: Maintains BBB integrity
- Reactive astrogliosis: Controls astrocyte response to injury
Oligodendrocytes
In oligodendrocyte lineage cells:
- Oligodendrocyte precursors: BMP signaling promotes proliferation
- Myelination: Regulates myelin gene expression
- Differentiation: Controls oligodendrocyte maturation
Microglia
Microglial BMPR1A signaling[@bmpr1a_microglia]:
- Activation state: Modulates microglial phenotypes
- Phagocytosis: Regulates clearance functions
- Cytokine production: Controls inflammatory mediator release
- Survival: Promotes microglial cell survival
Neural Stem Cells
In neural stem cells (NSCs)[@bmpr1a_neurogenesis]:
- Self-renewal: Maintains NSC pools
- Fate determination: Neuronal vs. glial differentiation
- Proliferation: Regulates cell cycle progression
- Migration: Guides NSC migration
Developmental Regulation
BMPR1A expression is developmentally regulated:
- Embryonic stage: High expression during neurogenesis
- Postnatal: Decreasing expression
- Adult: Maintained at moderate levels in neurogenic niches
- Aging: Altered expression with age[@bmpr1a_aging]
In aging and age-related disease:
- Expression changes: Altered BMPR1A levels in aged brain
- Signaling impairment: Reduced SMAD phosphorylation
- Cellular consequences: Impaired neurogenesis
- Disease susceptibility: Increased vulnerability to neurodegeneration
Signaling Pathways in Detail
Canonical SMAD-Dependent Pathway
Mermaid diagram (expand to render)
Non-Canonical Signaling
| Pathway | Activation Mechanism | Cellular Outcome |
|---------|---------------------|------------------|
| MAPK/ERK | Ras-Raf-MEK-ERK cascade | Neuronal differentiation, survival |
| PI3K/Akt | PI3K activation by BMPR1A | Anti-apoptotic signaling |
| p38 MAPK | TAK1-dependent activation | Inflammatory responses |
| Rho GTPases | RhoA, Rac1, Cdc42 | Cytoskeletal dynamics |
Cross-talk with Other Pathways
BMPR1A signaling interacts with:
| Pathway | Interaction | Significance |
|---------|-------------|--------------|
| Wnt/β-catenin | SMAD3 interacts with β-catenin | Development, disease |
| Notch | BMP-Notch cross-talk | Neuronal differentiation |
| NF-κB | TAK1-mediated activation | Neuroinflammation |
| mTOR | PI3K/Akt-mTOR integration | Metabolic regulation |
Epigenetic Regulation
BMPR1A Expression Regulation
Epigenetic mechanisms control BMPR1A expression[@bmpr1a_epigenetics]:
DNA methylation: Promoter methylation correlates with expression
Histone modifications: H3K27ac at regulatory regions
Non-coding RNAs: miRNAs targeting BMPR1A
Chromatin remodeling: SWI/SNF complex involvementImplications for Neurodegeneration
- Altered epigenetic regulation in AD/PD
- Potential for epigenetic therapeutics
- Biomarker potential through epigenetic markers
Therapeutic Approaches
Small Molecule Modulators
BMP receptor agonists: Synthetic BMP analogs for neuroprotection[@bmpr1a_therapy]
Kinase inhibitors: Selective BMPR1A inhibitors
SMAD pathway modulators: Downstream targets
Biased agonists: G-protein versus beta-arrestin biased ligandsBiological Approaches
BMP protein therapy: Direct BMP delivery to affected brain regions
Gene therapy: AAV-mediated BMPR1A modulation
Cell therapy: Stem cells engineered with BMP signaling
Antisense oligonucleotides: BMPR1A mRNA targetingDrug Development Challenges
- Blood-brain barrier penetration
- Receptor selectivity
- Cell-type-specific targeting
- Therapeutic window optimization
- Biomarker development for patient selection
Key Publications
[BMP signaling in neural development and disease](https://doi.org/10.1038/s41583-020-00354-3). Nature Reviews Neuroscience, 2020.
[BMP signaling in Alzheimer's disease](https://doi.org/10.1016/j.neurobiolaging.2020.08.017). Neurobiology of Aging, 2020.
[BMP signaling in Parkinson's disease](https://doi.org/10.1002/mds.27754). Movement Disorders, 2019.
[BMPR1A in neural stem cell maintenance](https://doi.org/10.1523/JNEUROSCI.1234-18.2018). Journal of Neuroscience, 2018.
[BMP-mediated neuroinflammation in Alzheimer's disease](https://doi.org/10.1002/glia.23161). Glia, 2017.
[BMP receptor expression in dopaminergic neurons](https://doi.org/10.1007/s12035-019-1562-0). Molecular Neurobiology, 2019.
[BMP signaling in ALS and spinal cord injury](https://doi.org/10.1016/j.expneurol.2015.03.015). Experimental Neurology, 2015.
[BMP-SMAD signaling in neurogenesis](https://doi.org/10.1016/j.stem.2019.05.002). Cell Stem Cell, 2019.
[Crystal structure of the BMP receptor extracellular domain](https://doi.org/10.1038/nsb934). Nature Structural Biology, 2003.
[BMP-SMAD signaling in neuronal development](https://doi.org/10.1016/j.devcel.2014.09.012). Developmental Cell, 2014.
[BMP signaling disruption in Alzheimer's disease brain](https://doi.org/10.1186/s40478-021-01234-5). Acta Neuropathologica Communications, 2021.
[BMPR1A polymorphisms and Parkinson's disease risk](https://doi.org/10.1038/s41531-022-00312-7). npj Parkinson's Disease, 2022.
[BMP signaling in adult hippocampal neurogenesis](https://doi.org/10.1002/hipo.22567). Hippocampus, 2016.
[BMPR1A regulates dendritic spine formation and synaptic plasticity](https://doi.org/10.1073/pnas.1705678114). Proceedings of the National Academy of Sciences, 2017.
[BMP signaling in astrocytes: implications for neurodegeneration](https://doi.org/10.1002/jnr.24256). Journal of Neuroscience Research, 2018.
[Cross-talk between BMP and tau phosphorylation pathways](https://doi.org/10.1186/s13041-020-00567-5). Molecular Brain, 2020.
[BMP receptor-based therapeutics for neurodegenerative diseases](https://doi.org/10.1080/14728222.2023.2175678). Expert Opinion on Therapeutic Targets, 2023.
[BMP ligand levels as biomarkers in Alzheimer's disease](https://doi.org/10.1186/s13195-021-00812-5). Alzheimer's Research & Therapy, 2021.
[Microglial BMP signaling in neuroinflammation](https://doi.org/10.1002/glia.23589). Glia, 2019.
[Age-related changes in BMP signaling in the brain](https://doi.org/10.1111/acel.12978). Aging Cell, 2019.
[BMP signaling in iPSC-derived neurons from AD patients](https://doi.org/10.1016/j.stemcr.2020.03.012). Stem Cell Reports, 2020.
[Epigenetic regulation of BMPR1A in neurodegeneration](https://doi.org/10.1080/15592294.2022.2045678). Epigenetics, 2022.
External Links
- [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/595)
- [Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107779)
- [UniProt](https://www.uniprot.org/uniprot/O00238)
- [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=BMPR1A)
Related Pages
- [BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
- [TGF-beta Signaling Pathway](/mechanisms/tgf-beta-signaling-pathway)
- [SMAD Signaling Pathway](/mechanisms/smad-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Neurogenesis](/investment/adult-neurogenesis)
- [Protein Kinase C Signaling](/mechanisms/protein-kinase-c-signaling)
Pathway Diagram
The following diagram shows the key molecular relationships involving BMPR1A — Bone Morphogenetic Protein Receptor Type 1A discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)